Evidence map›Paper›PMID 30043184›Full record

ReviewEuropean journal of nutrition2019

Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics.

Sebastian Torres, Emanuel Fabersani, Antonela Marquez, Paola Gauffin-Cano

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 2 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 2 syntheses or guidelines pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sebastian TorresInstituto de Bioprospección y Fisiología Vegetal (INBIOFIV), CONICET, Tucumán, Argentina.
Emanuel FabersaniFacultad de Agronomía y Zootecnia, Universidad Nacional de Tucumán, Tucumán, Argentina.
Antonela MarquezCentro de Referencia para Lactobacilos (CERELA), CONICET, Chacabuco 145 (4000), Tucumán, Argentina.
Paola Gauffin-CanoCentro de Referencia para Lactobacilos (CERELA), CONICET, Chacabuco 145 (4000), Tucumán, Argentina. pgauffin@cerela.org.ar.ORCID http://orcid.org/0000-0001-9397-6034
Consejo Nacional de Investigaciones Científicas y Técnicas · ARNational University of Tucumán · AR

Funding

Consejo Nacional de Investigaciones Científicas y Técnicas PIP215
6 · The paper itself

Abstract

purposeThe first part of this review focuses on the role of cells and molecules of adipose tissue involved in metabolic syndrome-induced inflammation and in the maintenance of this pathology. In the second part of the review, the potential role of probiotics-modulating metabolic syndrome-related inflammatory components is summarized and discussed.

methodsThe search for the current scientific literature was carried out using ScienceDirect, PubMed, and Google Scholar search engines. The keywords used were: metabolic syndrome, obesity, insulin resistant, adipose tissue, adipose tissue inflammation, chronic low-grade inflammation, immune cells, adipokines, cytokines, probiotics, and gut microbiota. RESULTS AND

conclusionsChronic low-grade inflammation that characterized metabolic syndrome can contribute to the development of the metabolic dysfunctions involved in the pathogenesis of its comorbidities. Adipose tissue is a complex organ that performs metabolic and immune functions. During metabolic syndrome, an imbalance in the inflammatory components of adipose tissue (immune cells, cytokines, and adipocytokines), which shift from an anti-inflammatory to a pro-inflammatory profile, can provoke metabolic syndrome linked complications. Further knowledge concerning the immune function of adipose tissue may contribute to finding better alternatives for the treatment or prevention of such disorders. The control of inflammation could result in the management of many of the pathologies related to metabolic syndrome. Due to the strong evidence that gut microbiota composition plays a role modulating the body weight, adipose tissue, and the prevalence of a low-grade inflammatory status, probiotics emerge as valuable tools for the prevention of metabolic syndrome and health recovery.

Indexed as

Adipose TissueHumansInflammationMetabolic SyndromeProbioticsAdipokinesAdipose tissueChronic low-grade inflammationMetabolic syndromeObesityProbiotics

Identifiers

PMID30043184
OpenAlexW2884495027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.